EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Axon Enterprise (AXON)

Industrials

Northcoast Research

AXON's impressive growth over the past several years has been a result of strong products, innovation, execution, acquisitions and partnerships. Unfortunately, it looks like one of those early partnerships has turned south and as Flock Safety emerges as a competitor to AXON in the ALPR, drone and RTCC space, it could impact the growth trajectory of AXON's recent Fusus acquisition. AXON's share price has surpassed Northcoast’s price target, and they are moving to a Neutral rating on valuation and concerns FY25 guidance will not live up to the Street’s lofty expectations.

Edition: 205

- 21 February, 2025


Axon Enterprise (AXON)

Industrials

Northcoast Research

The share price of AXON shot up nearly 30% following the release of Q3 results where revenue grew 32% and adjusted EBITDA margins hit recent record highs. The company has experienced sustained growth that few businesses could ever replicate and investor’s confidence is growing in AXON's ability to profitably invest in its future as well as the line of sight for sustained growth for the next three to four years with DraftOne, AI Era, Dedrone, Fusus as well as the market expansion opportunities with legacy products. While logic suggests there could be a pullback over the next few months, Northcoast maintains their Buy rating as they believe the shares will be even higher a year from now. Looking out to 2025 and 2026, consensus numbers remain too low and by a good margin.

Edition: 199

- 15 November, 2024


Axon Enterprise (AXON)

Technology

Poised to outperform - Northcoast's proprietary contract tracker points to a record quarter of bookings in 4Q21. They are expecting the shares' momentum will return, and return in a big way in 2022 as the company continues its streak of driving revenue and profitability growth above a combined 40%. AXON has laid the heavy groundwork building out its sales staff in new international markets, jails / correctional facilities and Federal agencies. Additional growth will come as agencies move up the value chain to add new features with its VR training modules the biggest draw for customers. TP $237 (70% upside).

Edition: 128

- 04 February, 2022